CPIX - Cumberland Pharmaceuticals GAAP EPS of $0.06 revenue of $10.9M
2023-08-08 17:12:18 ET
- Cumberland Pharmaceuticals press release ( NASDAQ: CPIX ): Q2 GAAP EPS of $0.06.
- Revenue of $10.9M (+5.8% Y/Y).
- $89.4 million in total assets, $52.5 million in total liabilities, and $36.8 million of shareholders' equity at the end of June 2023.
For further details see:
Cumberland Pharmaceuticals GAAP EPS of $0.06, revenue of $10.9M